XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.21.4

Earnings (Loss) Per Share (Tables) | 9 Months Ended
--- | ---
Nov. 30, 2021
Earnings Per Share [Abstract] |
Schedule of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings (loss) per share:
| Three Months Ended | Nine Months Ended
| November 30, 2021 |  | November 30, 2020 |  | November 30, 2021 |  | November 30, 2020
Net income (loss) for basic earnings (loss) per share available to common shareholders | $ | 74 |  |  | $ | (130) |  |  | $ | (132) |  |  | $ | (789) |
Less: Debentures fair value adjustment (1) (2) | (110) |  |  | — |  |  | (47) |  |  | — |
Add: interest expense on Debentures (1) (2) | 2 |  |  | — |  |  | 5 |  |  | — |
Net loss for diluted loss per share available to common shareholders | $ | (34) |  |  | $ | (130) |  |  | $ | (174) |  |  | $ | (789) |
Weighted average number of shares outstanding (000’s) - basic (3) (4) | 571,138 |  |  | 562,443 |  |  | 568,877 |  |  | 559,732 |
Effect of dilutive securities (000’s) |  |  |  |  |  |  |
Conversion of Debentures (1) (2) | 60,833 |  |  | — |  |  | 60,833 |  |  | — |
Weighted average number of shares and assumed conversions (000’s) diluted | 631,971 |  |  | 562,443 |  |  | 629,710 |  |  | 559,732 |
Earnings (loss) per share - reported |  |  |  |  |  |  |
Basic | $ | 0.13 |  |  | $ | (0.23) |  |  | $ | (0.23) |  |  | $ | (1.41) |
Diluted | $ | (0.05) |  |  | $ | (0.23) |  |  | $ | (0.28) |  |  | $ | (1.41) |
______________________________ (1) The Company has presented the dilutive effect of the Debentures using the if-converted method, assuming conversion at the beginning of the quarter for the three and nine months ended November 30, 2021. Accordingly, to calculate diluted loss per share, the Company adjusted net income (loss) by eliminating the fair value adjustment made to the Debentures and interest expense incurred on the Debentures for the three and nine months ended November 30, 2021, and added the number of shares that would have been issued upon conversion to the diluted weighted average number of shares outstanding. See Note 6 for details on the Debentures. (2) The Company has not presented the dilutive effect of the Debentures using the if-converted method in the calculation of diluted loss per share for the three and nine months ended November 30, 2020, as to do so would be antidilutive. See Note 6 for details on the Debentures. (3) The three and nine months ended November 30, 2021, includes approximately 1,421,945 common shares (Exchange Shares) remaining to be issued on the third anniversary date of the Cylance acquisition completed on February 21, 2019, in consideration for the acquisition. The three and nine months ended November 30, 2020, includes approximately 2,802,067 common shares to be issued in equal installments on the two anniversary dates of the Cylance acquisition thereafter, in consideration for the acquisition. There are no service or other requirements associated with the issuance of these shares. (4) The Company has not presented the dilutive effect of in-the-money options and RSUs that will be settled upon vesting by the issuance of new common shares in the calculation of diluted loss per share for the three and nine months ended November 30, 2021 and November 30, 2020, as to do so would be antidilutive.

X
- Definition [Table Text Block] for Schedule of Basic and Diluted Earnings Per Share [Table] + References No definition available. + Details
Name: | bbry_ScheduleofBasicandDilutedEarningsPerShareTableTextBlock
Namespace Prefix: | bbry_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration